Work

Prognostic Value of Month 1 Bone Marrow and PET MRD Status in CAR-T Therapy for Myeloma

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-166662

Authors: Radhika Bansal, Sikander Ailawadhi, Jeremy T. Larsen, Morie A Gertz, Matthew A. Hathcock, David Dingli, Prashant Kapoor, Taxiarchis Kourelis, Suzanne R. Hayman, Rahma M Warsame, Moritz Binder, Ricardo D Parrondo, Rafael Fonseca, P. Leif Bergsagel, Shaji K Kumar, Yi Lin

Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic in Arizona, Mayo Clinic Comprehensive Cancer Center (Florida), Mayo Clinic Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310119338

FWCI:

Cites:

Cited by:

Related to: 10